SEP 8, 2026 · OBSERVATIONAL STUDY
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
ClinicalTrials.gov
This is a registry record for a recruiting observational study with no results posted; it describes planned conduct and endpoints only, not evidence of efficacy or safety.
Reported
Planned enrollment2572
Primary outcome measureOverall survival period (OS)
Study designMulticenter retrospective observational